Staphylococcal biofilm: penetration and bioavailability of vancomycin with or without rifampin

被引：0

作者：

Daffinee, Kathryn E. ^{[1
]}

O'Neill, Emily T. ^{[1
,2
]}

Bleick, Callan R. ^{[2
]}

Williams, Geoff ^{[3
]}

Antoci, Valentin ^{[4
,5
]}

Garcia, Dioscaris ^{[4
,5
]}

LaPlante, Kerry L. ^{[1
,2
,6
]}

机构：

[1] Providence Vet Affairs Med Ctr, Infect Dis Res Program, Providence, RI 02908 USA

[2] Univ Rhode Isl, Coll Pharm, 02881, Ri, Kingston, Jamaica

[3] Brown Univ, Leduc Bioimaging Facil, Div Biol & Med, Providence, RI USA

[4] Brown Univ, Warren Alpert Sch Med, Dept Orthopaed, Providence, RI USA

[5] Rhode Isl Hosp, Diane N Weiss Ctr Orthopaed Trauma Res, Providence, RI USA

[6] Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2023年 / 106卷 / 03期

关键词：

Staphylococcus epidermidis; Biofilm; Vancomycin; Rifampin; Microscopy; AUREUS BACTEREMIA; EPIDERMIDIS; DAPTOMYCIN; THERAPY;

D O I：

10.1016/j.diagmicrobio.2023.115947

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We measured antibiotic penetration and bioavailability in staphylococcus biofilms using simulated human-ized concentrations of fluorescent vancomycin plus or minus rifampin. Vancomycin percent recovery across biofilm layers was:upper = 46%, middle = 40%, and lower = 33%. Vancomycin plus rifampin was not signifi-cantly different (P = 0.65). Addition of rifampin did not improve vancomycin penetration across biofilm layers.Published by Elsevier Inc.

引用

页数：3

共 50 条

[21] VANCOMYCIN IN SERIOUS STAPHYLOCOCCAL INFECTIONS
GERACI, JE
WELLMAN, WE
NICHOLS, DR
ARCHIVES OF INTERNAL MEDICINE, 1962, 109 (05) : 507 - +
[22] VANCOMYCIN IN THE TREATMENT OF STAPHYLOCOCCAL ENDOCARDITIS
GERACI, JE
HEILMAN, FR
PROCEEDINGS OF THE STAFF MEETINGS OF THE MAYO CLINIC, 1960, 35 (12): : 316 - 326
[23] STAPHYLOCOCCAL VENTRICULITIS TREATED WITH VANCOMYCIN
YOUNG, EJ
RATNER, RE
CLARRIDGE, JE
SOUTHERN MEDICAL JOURNAL, 1981, 74 (08) : 1014 - 1015
[24] Marked decrease of digoxin bioavailability by rifampin
Greiner, B
Fritz, P
Zundler, J
Kreichgauer, HP
Kroemer, HK
Eichelbaum, M
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R159 - R159
[25] Phosphoryicholine-Based Polymer Encapsulated Chitosan Nanoparticles Enhance the Penetration of Antimicrobials in a Staphylococcal Biofilm
Cao, Jingjing
Zhao, Yu
Liu, Yong
Tian, Shuang
Zheng, Chunxiong
Liu, Chenhui
Zhai, Yan
An, Yingli
Busscher, Henk J.
Shi, Linqi
Liu, Yang
ACS MACRO LETTERS, 2019, 8 (06) : 651 - 657
[26] INTRAOCULAR PENETRATION OF VANCOMYCIN
PRYOR, JG
LEOPOLD, IH
APT, L
ARCHIVES OF OPHTHALMOLOGY, 1962, 67 (05) : 608 - &
[27] ENTEROCOCCAL MENINGITIS - COMBINED VANCOMYCIN AND RIFAMPIN THERAPY
RYAN, JL
PACHNER, A
ANDRIOLE, VT
ROOT, RK
AMERICAN JOURNAL OF MEDICINE, 1980, 68 (03): : 449 - 451
[28] BIOASSAY FOR DETERMINATION OF VANCOMYCIN IN THE PRESENCE OF RIFAMPIN OR AMINOGLYCOSIDES
WALKER, CN
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (04) : 730 - 731
[29] EFFECTS OF A VANCOMYCIN-RIFAMPIN COMBINATION ON ENTEROCOCCI
WATANAKUNAKORN, C
TISONE, JC
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (05) : 915 - 916
[30] TREATMENT OF EXPERIMENTAL STAPHYLOCOCCAL INFECTIONS - EFFECT OF RIFAMPIN ALONE AND IN COMBINATION ON DEVELOPMENT OF RIFAMPIN RESISTANCE
MANDELL, GL
MOORMAN, DR
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (04) : 658 - 662

← 1 2 3 4 5 →